Publication | Closed Access

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

Maintenance StrategiesAio 0207MedicineCancer ManagementColorectal CancerMetastatic Colorectal CancerCancer TreatmentOncologyRadiation OncologyMolecular Oncology